Suchergebnisse - "Chilton, Robert J"

PubPharm (14)

1

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2023

von Moody, A. | Molina-Wilkins, M. | Clarke, G. | +8

2

Beyond the myocardium : Sodium-glucose co-transporter-2 inhibitors in heart failure

enthalten in: Diabetes, obesity & metabolism | 2021

von Chilton, R.

3

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes

enthalten in: Primary care diabetes | 2020

von Chilton, R. | Dungan, K. | Shubrook, J. | +1

4

Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2020

von Chilton, R.

5

enthalten in: The American journal of cardiology | 2017

von Chilton, R.

6

Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map

enthalten in: PLoS computational biology | 2014

von Nguyen, N. | Zhang, X. | Wu, C. | +4

7

Left ventricular remodeling : one small step for the extracellular matrix will translate to a giant leap for the myocardium

enthalten in: Congestive heart failure (Greenwich, Conn.) | 2013

von Yabluchanskiy, A. | Chilton, R. | Lindsey, M.

8

Matrix metalloproteinases : drug targets for myocardial infarction

enthalten in: Current drug targets | 2013

von Yabluchanskiy, A. | Li, Y. | Chilton, R. | +1

9

Is isolated systolic hypertension worse than combined systolic/diastolic hypertension?

enthalten in: Journal of clinical hypertension (Greenwich, Conn.) | 2012

von Ma, Y. | Yabluchanskiy, A. | Lindsey, M. | +1

10

Heart rate reduction : an old and novel candidate heart failure therapy

enthalten in: Hypertension (Dallas, Tex. : 1979) | 2012

von Ma, Y. | Chilton, R. | Lindsey, M.

CommentOn: Hypertension. 2012 May;59(5):949-57. - PMID 22493071